China · Delayed Price · Currency is CNY BeBetter Med Statistics
Total Valuation
BeBetter Med has a market cap or net worth of CNY 9.76 billion. The enterprise value is 8.25 billion.
| Market Cap | 9.76B |
| Enterprise Value | 8.25B |
Important Dates
The next estimated earnings date is Tuesday, November 24, 2026.
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BeBetter Med has 450.04 million shares outstanding. The number of shares has increased by 19.47% in one year.
| Current Share Class | 450.04M |
| Shares Outstanding | 450.04M |
| Shares Change (YoY) | +19.47% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 50.03% |
| Owned by Institutions (%) | 21.67% |
| Float | 178.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.13 |
| P/TBV Ratio | 6.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.78, with a Debt / Equity ratio of 0.00.
| Current Ratio | 26.78 |
| Quick Ratio | 26.39 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -3,797.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -13.46% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.00M |
| Employee Count | 177 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BeBetter Med has paid 17,623 in taxes.
| Income Tax | 17,623 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24.47 |
| 200-Day Moving Average | 33.81 |
| Relative Strength Index (RSI) | 40.30 |
| Average Volume (20 Days) | 3,860,330 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -214.66M |
| Pretax Income | -177.48M |
| Net Income | -177.50M |
| EBITDA | -206.95M |
| EBIT | -214.66M |
| Earnings Per Share (EPS) | -0.41 |
Balance Sheet
The company has 1.51 billion in cash and 3.73 million in debt, with a net cash position of 1.51 billion or 3.36 per share.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 3.73M |
| Net Cash | 1.51B |
| Net Cash Per Share | 3.36 |
| Equity (Book Value) | 1.59B |
| Book Value Per Share | 3.54 |
| Working Capital | 1.48B |
Cash Flow
In the last 12 months, operating cash flow was -119.98 million and capital expenditures -40.05 million, giving a free cash flow of -160.03 million.
| Operating Cash Flow | -119.98M |
| Capital Expenditures | -40.05M |
| Depreciation & Amortization | 7.72M |
| Net Borrowing | -21.96M |
| Free Cash Flow | -160.03M |
| FCF Per Share | -0.36 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BeBetter Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -19.47% |
| Shareholder Yield | -19.47% |
| Earnings Yield | -1.82% |
| FCF Yield | -1.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |